<bill session="118" type="s" number="708" updated="2024-04-17T23:52:03Z">
  <state datetime="2023-03-08">REFERRED</state>
  <status>
    <introduced datetime="2023-03-08"/>
  </status>
  <introduced datetime="2023-03-08"/>
  <titles>
    <title type="display">A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.</title>
    <title type="official" as="introduced">A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.</title>
  </titles>
  <sponsor bioguide_id="B000944"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2023-05-11"/>
    <cosponsor bioguide_id="S001184" joined="2023-03-08"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Medicaid"/>
    <term name="Mental health"/>
    <term name="Prescription drugs"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2023-04-04T13:32:40Z" status="Introduced in Senate">This bill requires the Centers for Medicare &amp; Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.</summary>
</bill>
